SEC reopens Nasdaq QBTC bitcoin options review after CME challenge

The Securities and Exchange Commission (SEC) has suspended its approval of Nasdaq PHLX’s QBTC bitcoin index options in order to revisit its May 2026 decision, following a jurisdictional challenge filed by CME Group that claims exclusive CFTC authority over the product.

Timeline of a regulatory showdown

The QBTC saga spans nearly a year of regulatory navigation. Nasdaq PHLX filed its proposed rule change on September 23, 2025, published in the Federal Register on September 29, 2025. The SEC designated a longer review period on November 3, 2025, initiated proceedings to approve or disapprove the rule change on December 23, 2025, then extended its timeline again on March 20, 2026. On May 15, 2026, the exchange submitted Amendment No. 1, replacing the initial filing in its entirety. Seven days later, on May 22, 2026, the SEC published an order granting accelerated approval.

That short-lived victory was undercut three weeks later by CME Group. On June 11, 2026, the Chicago-based operator filed a formal notice of challenge. The SEC responded by publishing, on July 31, 2026, an order for public inspection that stays the conditional approval and returns the file to the full Commission. QBTC remains suspended until the agency rules on the merits.

The stakes are not trivial: if CME’s argument prevails, the SEC would have no authority to approve QBTC. Nasdaq would then need to register as a futures or swaps platform with the CFTC, or restructure the contracts to track a regulated security such as a spot bitcoin ETF.

CME’s legal arguments against the SEC

CME Group is pressing a two-step argument. First, bitcoin is a commodity under U.S. law, and options tied to its value fall under the exclusive jurisdiction of the Commodity Futures Trading Commission (CFTC). Second, federal agencies cannot use their exemption powers to move a product from one regulator to another.

“The SEC’s May approval envisioned the CFTC granting exemptions that would let Nasdaq and the OCC offer the product through the securities markets — a workaround that CME is contesting.”

CME Group, June 11, 2026 challenge

CME already operates regulated bitcoin futures and options markets. QBTC would compete directly for the same trading flows, without Nasdaq registering under the CFTC framework that governs CME. CME also warns that the approval could create a precedent allowing securities exchanges to list derivatives on other commodities, opening the door to massive regulatory arbitrage.

One technical point strengthens CME’s position: the contracts proposed by Nasdaq rely on CME CF reference rates for both the underlying index (BRTI) and the final settlement price (BRRNY). The operator raises a coherence issue: why should a non-CFTC-registered exchange be allowed to use indices administered under CFTC rules to offer a derivative product?

Anatomy of the QBTC product

QBTC is a new type of bitcoin index option. The underlying index is the CME CF Bitcoin Real Time Index (BRTI), calculated and published every 200 milliseconds. The BRTI aggregates order book data from BTC/USD exchanges operated by major crypto venues meeting the CME CF Constituent Exchange Criteria. The index was launched in 2016 by CME Group and Crypto Facilities.

The administrator of the BRTI and the BRRNY (CME CF Cryptocurrency Reference Rate – New York Variant) is CF Benchmarks Ltd., regulated by the U.K. Financial Conduct Authority under the European Benchmark Regulation (EU BMR). The index is designed in accordance with the IOSCO Principles for Financial Benchmarks.

The final settlement price is the CF NQBTC Options Settlement Value, calculated on the expiration date by observing transactions over a one-hour window from 3:00 p.m. to 4:00 p.m. New York time. Those transactions are split into twelve 5-minute partitions, each producing a volume-weighted median (VWM); the final value is the arithmetic mean of the twelve VWMs, resulting in the BRRNY divided by a factor of 100.

The goal of using the BRRNY divided by 100 is to provide a replicable, manipulation-resistant reference rate for bitcoin that is synchronized with the close of the traditional U.S. options market.

Market stakes and precedents

QBTC fits into a broader push to integrate digital assets into traditional finance. The BRRNY already serves as the settlement index for CME’s bitcoin futures. As of July 18, 2024, spot bitcoin ETF products using the BRRNY as their reference rate represented $58 billion in assets under management, according to aggregated data from CF Benchmarks.

In September 2024, the SEC had approved options on BlackRock’s spot bitcoin ETF IBIT, a first for this type of product. Sean Feeney, head of U.S. options at Nasdaq, welcomed the decision: “We are pleased with the SEC’s approval of options on IBIT. We believe the ability to list and trade options on IBIT will protect and serve investors by providing them with an additional, lower-cost risk management tool to gain spot bitcoin exposure in their portfolios.” As of September 20, 2024, IBIT had become the world’s largest and most liquid bitcoin ETF, with over $22 billion in assets under management and a daily trading volume exceeding 25 million shares.

The ongoing re-examination does not amount to a rejection or permanent suspension of bitcoin options. It is part of the regulatory process to determine whether the May 2026 approval is consistent with existing legal authority. The outcome of this dispute could nevertheless shape future listings of bitcoin derivatives and reshape the regulatory framework applicable to digital assets in the United States.

Conclusion: a test for the SEC/CFTC boundary

The QBTC episode goes beyond a single suspended derivative. It stress-tests the historical split of authority between the SEC and the CFTC at a time when digital assets blur traditional categories. Three scenarios emerge heading into fall 2026: a full withdrawal of the approval, forcing Nasdaq to register with the CFTC or pivot to a securitized underlying; a partial validation that confines QBTC to a narrow index-options role; or a negotiated settlement between the two operators and the regulators that could serve as a precedent for future issuances.

In any case, the CME vs. Nasdaq battle redraws the regulatory risk map for issuers and pushes traditional players to clarify, product by product, which jurisdiction applies before any launch.

Sources

• CoinDesk — SEC to review Nasdaq bitcoin options approval after CME challenge (August 1, 2026)
• SEC — Public inspection order, file 34-105549
• TradersUnion — SEC freezes Nasdaq bitcoin options
• Nasdaq — SEC approves first-of-kind options on spot bitcoin ETF (IBIT)
• KuCoin News — SEC halts Nasdaq QBTC approval amid CME legal challenge

This article is for informational and educational purposes only. It does not constitute investment advice. Do your own research (DYOR) before making any decision.